FibroGen Investor FAQ
-
On which exchange and under what symbol are FibroGen’s shares traded?
-
FibroGen is listed on the NASDAQ Global Market under the ticker symbol FGEN.
-
​
-
What is your stock’s CUSIP?
-
31572Q
-
​
-
Where is FibroGen, Inc. incorporated?
-
FibroGen is incorporated in the State of Delaware.
-
​
-
Where is FibroGen headquartered?
-
FibroGen, Inc., headquarters are located at 409 Illinois Street, San Francisco, CA 94158.
-
​
-
How can I purchase or sell shares?
-
Shares may be purchased or sold through a stockbroker of your choice.
-
​
-
Can I purchase shares directly from the company?
-
No, FibroGen, Inc., does not have a direct stock purchase plan. Shares may be purchased through a stockbroker of your choice.
-
​
-
Do you anticipate paying a dividend?
-
FibroGen, Inc., does not foresee paying a dividend in the near future.
-
​
-
Who is FibroGen’s Transfer Agent?
-
American Stock Transfer & Trust Company LLC
6201 15th Avenue
Brooklyn, NY 11219
www.amstock.com
info@amstock.com
Tel: 800-937-5449 (US toll-free)
Tel: 718-921-8124 (from outside the US)
-
​
-
Who should I notify in the event of lost stock certificates, or a change of address?
-
Our shares are uncertificated. However, communication regarding change of address should be directed to our transfer agent, American Stock Transfer & Trust Company LLC, if you hold shares directly, or with your stockbroker if you purchased shares on the open market.
-
​
-
Who are FibroGen’s independent auditors?
-
PricewaterhouseCoopers LLP
488 Almaden Blvd, Suite 1800
San Jose, CA 95110
-
​
-
Who can I contact if I have an Investor Relations question?
-
You may contact FibroGen’s Investor Relations team at ir@fibrogen.com.
-